Stakeholder engagement for comparative effectiveness research in cancer care: Experience of the DEcIDE Cancer Consortium

Caprice C. Greenberg, Jennifer K. Wind, George J. Chang, Ronald C. Chen, Deborah Schrag

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Stakeholder input is a critical component of comparative effectiveness research. To ensure that the research activities of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network, supported by the Agency for Healthcare Research and Quality, translate into the greatest impact for everyday practice and policy-making in cancer, we were tasked with soliciting stakeholder input regarding priority areas in cancer-related comparative effectiveness research for the DEcIDE Cancer Consortium. Given the increasing emphasis on stakeholder engagement in research, many investigators are facing a similar task, yet there is limited literature to guide such efforts, particularly in cancer care. To help fill this gap, we present our approach to operationalizing stakeholder engagement and discuss it in the context of other recent developments in the area. We describe challenges encountered in convening stakeholders from multiple vantage points to prioritize topics and strategies used to mitigate these barriers. We offer several recommendations regarding how to best solicit stakeholder input to inform comparative effectiveness research in cancer care. These recommendations can inform other initiatives currently facing the challenges of engaging stakeholders in priority setting for cancer.

Original languageEnglish (US)
Pages (from-to)117-125
Number of pages9
JournalJournal of Comparative Effectiveness Research
Issue number2
StatePublished - 2013
Externally publishedYes


  • CER
  • cancer
  • comparative effectiveness research
  • stakeholder

ASJC Scopus subject areas

  • Health Policy


Dive into the research topics of 'Stakeholder engagement for comparative effectiveness research in cancer care: Experience of the DEcIDE Cancer Consortium'. Together they form a unique fingerprint.

Cite this